Parallel Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.3K | Buy |
1,924
+855
| +80% | +$14.8K | ﹤0.01% | 1927 |
|
|
2025
Q1 | $23.4K | Buy |
1,069
+332
| +45% | +$7.26K | ﹤0.01% | 2043 |
|
|
2024
Q4 | $23.5K | Sell |
737
-1,142
| -61% | -$36.4K | ﹤0.01% | 2048 |
|
|
2024
Q3 | $54.2K | Buy |
1,879
+250
| +15% | +$7.21K | ﹤0.01% | 1573 |
|
|
2024
Q2 | $62.5K | Buy |
1,629
+88
| +6% | +$3.38K | ﹤0.01% | 1397 |
|
|
2024
Q1 | $90.6K | Buy |
1,541
+44
| +3% | +$2.59K | ﹤0.01% | 1218 |
|
|
2023
Q4 | $89.6K | Buy |
1,497
+71
| +5% | +$4.25K | ﹤0.01% | 1158 |
|
|
2023
Q3 | $54.2K | Buy |
1,426
+470
| +49% | +$17.9K | ﹤0.01% | 1354 |
|
|
2023
Q2 | $87.1K | Buy |
956
+14
| +1% | +$1.28K | ﹤0.01% | 1138 |
|
|
2023
Q1 | $62.1K | Buy |
942
+868
| +1,173% | +$57.3K | ﹤0.01% | 1272 |
|
|
2022
Q4 | $3.83K | Sell |
74
-7
| -9% | -$362 | ﹤0.01% | 2440 |
|
|
2022
Q3 | $6K | Buy |
81
+7
| +9% | +$519 | ﹤0.01% | 2166 |
|
|
2022
Q2 | $3K | Sell |
74
-56
| -43% | -$2.27K | ﹤0.01% | 2399 |
|
|
2022
Q1 | $6K | Sell |
130
-2
| -2% | -$92 | ﹤0.01% | 2200 |
|
|
2021
Q4 | $6K | Buy |
132
+73
| +124% | +$3.32K | ﹤0.01% | 2290 |
|
|
2021
Q3 | $2K | Hold |
59
| – | – | ﹤0.01% | 2625 |
|
|
2021
Q2 | $4K | Hold |
59
| – | – | ﹤0.01% | 2319 |
|
|
2021
Q1 | $3K | Hold |
59
| – | – | ﹤0.01% | 2309 |
|
|
2020
Q4 | $3K | Sell |
59
-51
| -46% | -$2.59K | ﹤0.01% | 2150 |
|
|
2020
Q3 | $3K | Sell |
110
-45
| -29% | -$1.23K | ﹤0.01% | 2145 |
|
|
2020
Q2 | $5K | Buy |
+155
| New | +$5K | ﹤0.01% | 1930 |
|